Oryzon Genomics S.A. (ORYZF) Financials
ORYZF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 186.7 million | 30.8 million |
| Dec. 31, 2025 | 169.6 million | 31.3 million |
| Sept. 30, 2025 | 171.3 million | 34.1 million |
| June 30, 2025 | 163.1 million | 28.4 million |
ORYZF Free Cash Flow and Stock based compensation
No data available :(
ORYZF Net Income
No data available :(
ORYZF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | - | - | - |
| Dec. 31, 2025 | 33.3 million | 7.9 million | 12282 |
| Sept. 30, 2025 | 40.5 million | 4.8 million | 19467 |
| June 30, 2025 | 36.7 million | 5.9 million | 54061 |
ORYZF Shares Outstanding
ORYZF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 5.1 million | 1.5 million | - |
| Dec. 31, 2025 | - | 5.2 million | -2.9 million | - |
| Sept. 30, 2025 | - | 3.9 million | 1.2 million | - |
| June 30, 2025 | - | 1.1 million | 1.7 million | 536419 |
ORYZF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | - |
| Dec. 31, 2025 | - | 37022 |
| Sept. 30, 2025 | - | 37988 |
| June 30, 2025 | 5.0 million | 173553 |
ORYZF
Price: $3.66
52 week price:
Earnings Per Share: -0.03 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 283.3 million